Andrew Poklepovic

Also affiliated with Virginia Cancer Institute, VCU Massey Comprehensive Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma”.

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

New England Journal of Medicine(2023)10.1056/nejmoa2211437

N/A

6.5DataRank · unranked

846 citations

Megan Othus, Yuanbin Chen, G. Paul Wright, Kathleen J. Yost, John Hyngstrom +48 more

Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers

Journal of Clinical Investigation(2021)10.1172/jci152670

N/A

2.1DataRank · unranked

86 citations

Leslie Cope, Amanda N. Ruggieri, Robert A. Anders, Anne M. Noonan, Laura W. Goff +24 more

T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010294

N/A

0.510DataRank · unranked

16 citations

Xiaoyan Deng, Dipankar Bandyopadhyay, Michael O. Idowu, Taylor M. Jenkins, Maciej Kmieciak +16 more

A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors

Anti-Cancer Drugs(2024)10.1097/cad.0000000000001584

N/A

0.370DataRank · unranked

5 citations

Sarah Gordon, Sejal Kothadia, William P. McGuire, Leroy R. Thacker, Xiaoyan Deng +9 more

Multiple Immunotherapy-Related Cardiovascular Sequelae

CJC Open(2022)10.1016/j.cjco.2022.11.018

N/A

0DataRank · unranked

1 citations

David Chuquin, Ariel Sindel, Andrew Poklepovic, Antonio Abbate, Wendy Bottinor +1 more

Immune Checkpoint Inhibitor Rechallenge in a Patient With Previous Fulminant Myocarditis

The American Journal of Cardiology(2023)10.1016/j.amjcard.2023.04.037

N/A

0DataRank · unranked

11 citations

Yiwei Hang, Laura K. Pritchard, Andrew Poklepovic, Wendy Bottinor, Sherin M. Menachery

A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11503

N/A

0DataRank · unranked

35 citations

Jacob B. Allred, Scott M. Schuetze, Elizabeth J. Davis, Michael J. Wagner, Andrew Poklepovic +10 more

Tumor cell p38 inhibition to overcome immunotherapy resistance

Research Square(2023)10.21203/rs.3.rs-3183496/v1

N/A

0DataRank · unranked

5 citations

Rebekah Dadey, Ryan C. Augustin, Sarah Newman, Krishna B. Singh, Rose Doerfler +26 more

Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07551-z

N/A

0DataRank · unranked

12 citations

H. Boutrid, Mahmoud Kassem, Mahmoud Abdel‐Rasoul, Cynthia Timmers, Maryam B. Lustberg +19 more

SWOG/NCI Phase II Dual Anti–CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0606

N/A

0DataRank · unranked

11 citations

Megan Othus, Sandip Pravin Patel, Kelly J. Wilkinson, Emily M. Whitman-Purves, Jayanthi Lea +21 more

Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial Sarcoma

Research Square(2024)10.21203/rs.3.rs-4362092/v1

N/A

0DataRank · unranked

3 citations

Konstantinos Floors, Carter K. Fairchild, Jinxiu Li, Kun Zhang, Jane L. Roberts +34 more

Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial Sarcoma

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.25.591023

N/A

0DataRank · unranked

0 citations

Carter K. Fairchild, Jinxiu Li, Kun Zhang, Jane L. Roberts, Richard Kurupi +34 more

Phase II Study of Sunitinib in Tumors With c-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol V

JCO Precision Oncology(2024)10.1200/po-24-00514

N/A

0DataRank · unranked

0 citations

Zihe Song, Andrew Poklepovic, Eric A. Collisson, James A. Zwiebel, Robert J. Gray +14 more

Targeting SUMOylation promotes cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcoma

Nature Communications(2025)10.1038/s41467-025-64665-8

N/A

0DataRank · unranked

8 citations

Carter K. Fairchild, Jinxiu Li, Kun Zhang, Jane L. Roberts, Richard Kurupi +42 more

Fingolimod Augments Monomethylfumarate Killing of GBM Cells

Frontiers in Oncology(2020)10.3389/fonc.2020.00022

N/A

0DataRank · unranked

12 citations

Laurence Booth, Jane L. Roberts, Andrew Poklepovic, John F. Hancock, Paul Dent

Understanding the Role of Patient-Reported Outcomes for Decision-Making in Early-Phase Dose-Finding Clinical Trials

Current Oncology(2025)10.3390/curroncol32030176

N/A

0DataRank · unranked

4 citations

Nolan A. Wages, Emily Liu, Arnethea L. Sutton, Andrew Poklepovic, Richard Brown

Phase I study of regorafenib and sildenafil in advanced solid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3593

N/A

0DataRank · unranked

4 citations

Sarah Gordon, William P. McGuire, Leroy R. Thacker, Xiaoyan Deng, Mary Beth Tombes +5 more

Osimertinib-resistant NSCLC cells activate ERBB2 and YAP/TAZ and are killed by neratinib

Biochemical Pharmacology(2021)10.1016/j.bcp.2021.114642

N/A

0DataRank · unranked

22 citations

Laurence Booth, Andrew Poklepovic, Daniel D. Von Hoff, Jennifer Martinez, Yong Zhou +2 more

Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001595

N/A

0DataRank · unranked

19 citations

Wenjie Liu, Shixian Chen, Xueqian Cheng, Patrick A Paez, Tuanwei Sun +10 more